Aardvark Therapeutics AARD
NASDAQ AARD
$5.37 +0.02 (+0.37%)
As of: Sep 30, 2026 · 12:36 PM EDT

Aardvark Therapeutics, Inc. (AARD) Retained Earnings (2024 - 2026)

Updated

Aardvark Therapeutics' Retained Earnings came in at -$151.9 million for Q2 2026, compared with -$82 million a year earlier.

Analysis

Aardvark Therapeutics, Inc. (AARD) Retained Earnings (2024 - 2026) Analysis & Trends

At the end of FY2025, Aardvark Therapeutics' Retained Earnings was -$115.92 million.

  • Going back by year, Retained Earnings was -$58.33 million in FY2024.
  • Business Quant data shows AARD's Retained Earnings at -$137.51 million (Q1 2026), -$115.92 million (Q4 2025) and -$98.32 million (Q3 2025) in the three quarters before Q2 2026.
Peer Set

Peer Comparison

Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2026 -151.90 Mn
Mar 31, 2026 -137.51 Mn
Dec 31, 2025 -115.92 Mn
Sep 30, 2025 -98.32 Mn
Jun 30, 2025 -82.00 Mn
Mar 31, 2025 -67.64 Mn
Dec 31, 2024 -58.33 Mn
API Access

Aardvark Therapeutics, Inc. Retained Earnings API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=retained-earnings&ticker=AARD&period=max&api_key=YOUR_API_KEY